Medicare Enrolled

Dr. Paul Gennaro, MD

Neurology · West Long Branch, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
107 MONMOUTH RD, West Long Branch, NJ 07764
7329351850
In practice since 2006 (20 years)
NPI: 1942268412 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gennaro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gennaro? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gennaro

Dr. Paul Gennaro is a neurology specialist in West Long Branch, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gennaro performed 1,113 Medicare services across 818 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gennaro received a total of $4,168 from 49 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gennaro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 33% volume in NJ $4,168 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,113
Medicare services
Top 33% in NJ for neurology
818
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~56 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
384 $87 $121
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
182 $54 $72
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
174 $132 $184
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
159 $108 $162
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
57 $83 $110
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
54 $146 $214
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
47 $95 $137
Nerve conduction study, 1-2 tests
A test that measures how well nerves send electrical signals to evaluate nerve function.
29 $77 $107
New patient office visit, complex (60-74 min) 27 $168 $225
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$4,168
Total received (2018-2023)
Avg $695/year across 6 years
Top 37% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,114 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$54 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$1,101
2022
$725
2021
$450
2020
$322
2019
$1,128
2018
$443

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$182
UCB, Inc.
$154
PFIZER INC.
$153
ARGENX US, INC.
$72
Eisai Inc.
$53
Inspire Medical Systems, Inc.
$48
Genentech USA, Inc.
$48
Novartis Pharmaceuticals Corporation
$47
SK Life Science, Inc.
$37
Jazz Pharmaceuticals Inc.
$33
Lundbeck LLC
$33
Harmony Biosciences LLC
$31
Neurocrine Biosciences, Inc.
$29
Azurity Pharmaceuticals, Inc.
$27
Biogen, Inc.
$26
Lilly USA, LLC
$18
Alexion Pharmaceuticals, Inc.
$18
Amylyx Pharmaceuticals, Inc.
$17
Amneal Pharmaceuticals LLC
$17
Axsome Therapeutics, Inc.
$16
Celgene Corporation
$16
Teva Pharmaceuticals USA, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Top 3 companies account for 44.4% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$613
UCB, Inc.
$481
Biogen, Inc.
$329
ABBVIE INC.
$222
JAZZ PHARMACEUTICALS INC.
$173
PFIZER INC.
$153
Teva Pharmaceuticals USA, Inc.
$142
Greenwich Biosciences, Inc.
$138
Alexion Pharmaceuticals, Inc.
$129
Sunovion Pharmaceuticals Inc.
$124
Biohaven Pharmaceutical Holding Company Ltd.
$118
ARGENX US, INC.
$117
Genentech USA, Inc.
$112
Amgen Inc.
$103
Amneal Pharmaceuticals LLC
$99
Eisai Inc.
$92
Adamas Pharmaceuticals, Inc.
$71
EISAI INC.
$70
AbbVie Inc.
$64
Biohaven Pharmaceuticals, Inc.
$61
Lundbeck LLC
$60
Mitsubishi Tanabe Pharma America, Inc.
$58
Harmony Biosciences LLC
$49
Inspire Medical Systems, Inc.
$48
Lilly USA, LLC
$48
Jazz Pharmaceuticals Inc.
$48
SK Life Science, Inc.
$37
Neurocrine Biosciences, Inc.
$29
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Mallinckrodt LLC
$28
Azurity Pharmaceuticals, Inc.
$27
Validus Pharmaceuticals LLC
$25
HARMONY BIOSCIENCES LLC
$25
Zyla Life Sciences
$24
IMPEL PHARMACEUTICALS INC.
$17
AQUESTIVE THERAPEUTICS, INC.
$17
Amylyx Pharmaceuticals, Inc.
$17
Corium, LLC
$17
Axsome Therapeutics, Inc.
$16
Celgene Corporation
$16
Collegium Pharmaceutical, Inc.
$15
Allergan Inc.
$15
ACADIA Pharmaceuticals Inc
$15
IDORSIA PHARMACEUTICALS US INC
$14
Impax Laboratories, Inc.
$14
Promius Pharma LLC
$14
GENZYME CORPORATION
$13
Assertio Therapeutics, Inc.
$13
Acorda Therapeutics, Inc
$13
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Briviact · CAMBIA · COMIRNATY · Dayvigo · ELYXYB - celecoxib · EMGALITY · Enspryng · Epidiolex · Equetro · Fycompa · GILENYA · GOCOVRI · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KYNMOBI · Leqembi · MAYZENT · NAMZARIC · NORTHERA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · Ocrevus · Ongentys · PAXLOVID · PLEGRIDY · QULIPTA · QUVIVIQ · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Sunosi · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XYREM · XYWAV · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in West Long Branch?
Compare neurologists in the West Long Branch area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
139
Per 100K population
21.6
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
1.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gennaro is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gennaro experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gennaro performed 384 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gennaro receive payments from pharmaceutical companies?
Yes. Dr. Gennaro received a total of $4,168 from 49 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gennaro's costs compare to other neurologists in West Long Branch?
Dr. Gennaro's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gennaro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →